EP Patent

EP3682879A1 — Processes and intermediates in the preparation of c5ar antagonists

Assigned to Chemocentryx Inc · Expires 2020-07-22 · 6y expired

What this patent protects

Intermediates and methods are provided for the preparation of selected C5aR antagonist compounds.

USPTO Abstract

Intermediates and methods are provided for the preparation of selected C5aR antagonist compounds.

Drugs covered by this patent

Patent Metadata

Patent number
EP3682879A1
Jurisdiction
EP
Classification
—
Expires
2020-07-22
Drug substance claim
No
Drug product claim
No
Assignee
Chemocentryx Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.